Authors:
OGGERO A
BONGIOANNI MR
MARZANO A
AIMO G
GENTILE E
RIZZETTO M
DURELLI L
Citation: A. Oggero et al., THYROID AND LIVER AUTOIMMUNITY DURING INTERFERON (IFN) TREATMENT FOR MULTIPLE-SCLEROSIS (MS) MAY BE AT TIMES LETHAL, Neurology, 48(3), 1997, pp. 4075-4075
Authors:
DURELLI L
SARACCO G
RIZZETTO M
PAGNI R
VERDUN E
BONGIOANNI MR
BERGAMASCO B
Citation: L. Durelli et al., AUTOIMMUNE SIDE-EFFECT PROFILE DURING CHRONIC INTERFERON (IFN) THERAPY FOR MULTIPLE-SCLEROSIS (MS), Neurology, 48(3), 1997, pp. 4076-4076
Authors:
FERRERO B
AIMO G
PAGNI R
BERGAMASCO B
BONGIOANNI MR
BERGAMINI L
DURELLI L
Citation: B. Ferrero et al., MODIFIED AND IMPROVED ANTIACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY-ASSAY - COMPARISON OF ANALYTICAL AND CLINICAL-PERFORMANCE WITH CONVENTIONAL ANTI-ACHR ANTIBODY-ASSAY, Clinical chemistry, 43(5), 1997, pp. 824-831
Authors:
DURELLI L
BONGIOANNI MR
FERRERO B
FERRI R
IMPERIALE D
BRADAC GB
BERGUI M
GEUNA M
BERGAMINI L
BERGAMASCO B
Citation: L. Durelli et al., INTERFERON ALPHA-2A TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS - DISEASE-ACTIVITY RESUMES AFTER STOPPING TREATMENT, Neurology, 47(1), 1996, pp. 123-129
Authors:
BONGIOANNI MR
DURELLI L
FERRERO B
IMPERIALE D
OGGERO A
VERDUN E
AIMO G
PAGNI R
GEUNA M
BERGAMASCO B
Citation: Mr. Bongioanni et al., SYSTEMIC HIGH-DOSE RECOMBINANT-ALPHA-2A-INTERFERON THERAPY MODULATES LYMPHOKINE PRODUCTION IN MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 143(1-2), 1996, pp. 91-99
Authors:
DURELLI L
BONGIOANNI MR
FERRERO B
VERDUN E
RIVA A
GUENA M
BRADAC GB
BERGAMASCO B
BERGAMINI L
Citation: L. Durelli et al., CHRONIC ALFA INTERFERON (IFNA) TREATMENT FOR MULTIPLE-SCLEROSIS (MS) MODULATES CYTOKINE PRODUCTION RATHER THAN ANTIGEN PRESENTATION PROCESS, Neurology, 45(4), 1995, pp. 234-234
Authors:
FERRERO B
DURELLI L
BONGIOANNI MR
AIMO G
VERDUN E
BERGAMASCO B
Citation: B. Ferrero et al., DECREASED ANTIACETYLCHOLINE RECEPTOR ANTIBODY (ACHR AB) BINDING AVIDITY AFTER HIGH-DOSE GAMMA-GLOBULIN (HIG) CORRELATES WITH CLINICAL EFFICACY IN MYASTHENIA-GRAVIS (MG), Neurology, 45(4), 1995, pp. 283-284
Authors:
DURELLI L
BONGIOANNI MR
FERRI R
CAVALLO R
AIMO G
FERRERO B
RIVA A
BRADAC GB
BERGAMASCO B
BERGAMINI L
Citation: L. Durelli et al., INTERFERON (IFN)-ALPHA(2A) TREATMENT OF RELAPSING REMITTING (R/R) MULTIPLE-SCLEROSIS (MS) - DISEASE-ACTIVITY RESUMES AFTER STOPPING TREATMENT/, Neurology, 44(4), 1994, pp. 10000358-10000358
Authors:
DURELLI L
BONGIOANNI MR
CAVALLO R
FERRERO B
FERRI R
FERRIO MF
BRADAC GB
RIVA A
VAI S
GEUNA M
BERGAMINI L
BERGAMASCO B
Citation: L. Durelli et al., CHRONIC SYSTEMIC HIGH-DOSE RECOMBINANT INTERFERON ALFA-2A REDUCES EXACERBATION RATE, MRI SIGNS OF DISEASE-ACTIVITY, AND LYMPHOCYTE INTERFERON-GAMMA PRODUCTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Neurology, 44(3), 1994, pp. 406-413
Authors:
BONGIOANNI MR
FERRIO MF
FERRERO B
VAI S
GEUNA M
DURELLI L
Citation: Mr. Bongioanni et al., CHRONIC SYSTEMIC RECOMBINANT-ALPHA-2A-INTERFERON (R-ALPHA(2A)-IFN) INHIBITS LYMPHOCYTE GAMMA-IFN PRODUCTION IN MS, Neurology, 43(4), 1993, pp. 164-164
Authors:
DURELLI L
CAVALLO R
FERRERO B
BONGIOANNI MR
DUTTO A
PECCHIO F
BERGAMASCO B
Citation: L. Durelli et al., DOES AN ACUTE INCREASE OF ANTIACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY (AB) TITER CONTRIBUTE TO CORTICOSTEROID (ST)-INDUCED WORSENING OF MG, Neurology, 43(4), 1993, pp. 165-165